Neuralink’s Brain Implant Receives FDA’s Approval for First Human Trials

Neuralink, the brain-implant initiative founded by Elon Musk, has received FDA’s approval for its first human trials. The company had faced rejection in early 2022, but it has managed to iron out its issues with the device’s battery and wire migration. While recruitment is not yet open, Neuralink is set to conduct its first-in-human clinical study soon. If successful, the implant could help treat neurological diseases and even restore functionality to those with a severed spinal cord. Musk’s ultimate goal with the technology is to avoid humans being intellectually overwhelmed by AI.

Leggi anche:  Neuralink riceve l’autorizzazione per testare impianti cerebrali sugli esseri umani





Una replica a “Neuralink’s Brain Implant Receives FDA’s Approval for First Human Trials”

  1. Avatar Riccardo

    This is a groundbreaking development in the field of neurotechnology. Neuralink’s brain implant has the potential to revolutionize the way we treat neurological disorders and injuries, and even enhance human capabilities. However, it’s important to ensure the safety and ethical use of such technology, especially when it comes to the potential risks involved. It’ll be interesting to see how Neuralink’s first human trials go and what the future holds for this innovative initiative.

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *